Patients who have heart failure with preserved ejection fraction (HFpEF) and high blood pressure in the lungs (pulmonary hypertension) experienced significant improvements in blood pressure and vascular health after taking…
A new cross-sectional study published in the journal of Arthritis Care & Research revealed that symptomatic knee osteoarthritis (OA) is a barrier to glycemic control in type 2 diabetes mellitus…
Many people with an aggressive blood cancer called diffuse large B cell lymphoma are cured by the current gold standard of treatment: an antibody designed to wipe out cancerous B…
USA: Researchers have found in a new study that lowering air pollution levels could play a significant role in delaying the onset and progression of physical disability among aging adults.…
CAR-T therapy is toting up more remissions in autoimmune disease, and generating a flood of experimentation and investment.
Researchers have found in a new study that high-frequency oscillatory ventilation (HFOV) may reduce the incidence of bronchopulmonary dysplasia (BPD) compared to conventional mechanical ventilation (CMV) in infants born at…
Researchers have found in a new study that among postmenopausal women, a higher Oxidative Balance Score (OBS)—reflecting a healthy diet and lifestyle—is associated with better periodontal health. Conversely, a low…
In this edition of Health Tech: FDA rejects a proposal to deregulate certain types of AI devices, pharma invests $50 million in DTx, and more.
Steve Ubl, chief executive of PhRMA, plans to step down at the end of the year, after more than a decade leading the main trade group for brand-name drug makers
The traditional biotech venture model under pressure, PhRMA chief Ubl to exit, and other biotech news from The Readout